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Aims
To compare the degree of uptake 
of lipophilic compounds by 
chylomicrons ex-vivo and by 
chylomicron-like artificial emulsion
in-vitro to the corresponding 
intestinal lymphatic bioavailability 
reported in rats.
To evaluate the utilization of 
these correlations as a predictive 
measurement of the lymphatic 
bioavailability potential of lipophilic 
drugs.
Methods
 9 lipophilic compounds (listed in Table 
1) at a concentration of 1.75 × 10-6 M 
were incubated for 1 hour with 
chylomicrons separated from rat blood or 
with commercially available artificial 
chylomicron-like emulsion at pH 7.4.
 The lymphatic bioavailability of tested 
compounds reported in-vivo in rats was 
correlated with the degree of uptake by 
chylomicrons ex-vivo and by chylomicron-
like emulsion in-vitro.
Conclusions
Both ex-vivo and in-vitro methods provide a good alternative to the 
complicated and expensive in-vivo studies of intestinal lymphatic transport 
of lipophilic molecules.
The degree of association of lipophilic compounds with chylomicrons
depends mainly on the triglyceride content of lipoproteins, however surface 
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Results
A strong linear correlation was found between the degree of association of compounds with chylomicrons ex-vivo and the 
lymphatic transport reported in rats (r2 = 0.94) (Fig 2). 
The correlation between the degree of association of lipophilic molecules with chylomicron-like emulsion in-vitro and the 
lymphatic transport was slightly weaker (r2 = 0.91) (Fig 3). 
Physicochemical properties traditionally used to predict the intestinal lymphatic transport of lipophilic compounds have shown 
limited correlation with lymphatic bioavailability of tested molecules (Table 1 and Fig. 3A and 3B).
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Figure 4. Lymphatic availability of tested drugs (% of dose) vs. 
logP (A) and TG solubility (B).
Figure 1. Schematic presentation of intestinal lymphatic absorption of 
lipophilic drugs. MM, mixed micelle; D, drug; LCFA, long chain fatty 
acids; 2-MG, 2-monoglyceride; SER, smooth endoplasmic reticulum; 
RER, rough endoplasmic reticulum; TGd, triglycerides rich droplet; 
PLp, primordial lipoprotein; CM, chylomicron. 
Table 1. Summary of physicochemical 
properties of tested drugs
Figure 2. Lymphatic availability of tested drugs (% of dose) vs. 
degree of association of drugs with isolated CM in the ex-vivo model 
(% of amount).
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Association of a drug with chylomicrons in the enterocyte is the main step in the intestinal lymphatic route of absorption of lipophilic 
molecules (Fig. 1). Since the animal models currently used to estimate the lymphatic absorption of drugs are very difficult to 
perform, there is a clear need for fast and efficient models to predict the intestinal lymphatic bioavailability potential of lipophilic 
molecules. 


























































































Figure 3. Lymphatic availability of tested drugs (% of dose) vs. 
degree of association of drugs with artificial emulsion in the in-vitro
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